Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections

Pediatrics International

Volumn 55, Issue 1, 2013, Pages 49-53

  Cho, Hye Jung ^a   Shim, So Yeon ^a   Son, Dong Woo ^a   Sun, Yong Han ^a   Tchah, Hann ^a   Jeon, In Sang ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

newborn infants; respiratory syncytial virus infections; respiratory tract infections

Indexed keywords

OXYGEN;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONAVIRUS; CROWDING; DISEASE SEVERITY; DYSPNEA; FEMALE; HOSPITALIZATION; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN RHINOVIRUS; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; NEWBORN; NOSE SMEAR; OXYGEN THERAPY; PARAINFLUENZA VIRUS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; VIRUS IDENTIFICATION; VIRUS INFECTION;

BRONCHIOLITIS, VIRAL; DNA, VIRAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; MALE; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD;

EID: 84874091610     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03727.x     Document Type: Article

References (32)

1. Cilla G, Onate E, Perez-Yarza EG, Montes M, Vicente D, Perez-Trallero E,. Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection. J. Med. Virol. 2008; 80: 1843-1849.
2. Calvo C, Garcia-Garcia ML, Blanco C, Pozo F, Flecha IC, Perez-Brena P,. Role of rhinovirus in hospitalized infants with respiratory tract infections in Spain. Pediatr. Infect. Dis. J. 2007; 26: 904-908.
3. Regamey N, Kaiser L, Roiha HL, et al. Viral etiology of acute respiratory infections with cough in infancy: A community-based birth cohort study. Pediatr. Infect. Dis. J. 2008; 27: 100-105.
4. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C,. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect. Dis. 2002; 2: 25-32.
5. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet 2010; 375: 1545-1555.
6. Garcia CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 2010; 126: 1453-1460.
7. Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G,. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr. Infect. Dis. J. 2012; 31: 5-9.
8. Rossi GA, Medici MC, Arcangeletti MC, et al. Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics. Eur. J. Pediatr. 2007; 166: 1267-1272.
9. Langley GF, Anderson LJ,. Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr. Infect. Dis. J. 2011; 30: 510-517.
10. Carbonell-Estrany X, Quero J,. Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons. Pediatr. Infect. Dis. J. 2001; 20: 874-879.
11. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jimenez J, et al. FLIP-2 Study: Risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr. Infect. Dis. J. 2008; 27: 788-793.
12. Houben ML, Bont L, Wilbrink B, et al. Clinical prediction rule for RSV bronchiolitis in healthy newborns: Prognostic birth cohort study. Pediatrics 2011; 127: 35-41.
13. Bonzel L, Tenenbaum T, Schroten H, Schildgen O, Schweitzer-Krantz S, Adams O,. Frequent detection of viral coinfection in children hospitalized with acute respiratory tract infection using a real-time polymerase chain reaction. Pediatr. Infect. Dis. J. 2008; 27: 589-594.
14. Lim JS, Woo SI, Kwon HI, Baek YH, Choi YK, Hahn YS,. Clinical characteristics of acute lower respiratory tract infection due to 13 respiratory viruses detected by multiplex PCR in children. Korean J. Pediatr. 2010; 53: 373-379.
15. Khadadah M, Essa S, Higazi Z, Behbehani N, Al-Nakib W,. Respiratory syncytial virus and human rhinoviruses are the major causes of severe lower respiratory tract infections in Kuwait. J. Med. Virol. 2010; 82: 1462-1467.
16. Louie JK, Roy-Burman A, Guardia-Labar L, et al. Rhinovirus associated with severe lower respiratory tract infections in children. Pediatr. Infect. Dis. J. 2009; 28: 337-339.
17. van der Zalm MM, van Ewijk BE, Wilbrink B, Uiterwaal CS, Wolfs TF, van der, Ent CK,. Respiratory pathogens in children with and without respiratory symptoms. J. Pediatr. 2009; 154: 396-400.
18. Peltola V, Waris M, Osterback R, Susi P, Ruuskanen O, Hyypia T,. Rhinovirus transmission within families with children: Incidence of symptomatic and asymptomatic infections. J. Infect. Dis. 2008; 197: 382-389.
19. Ko JH, Kim JH, Kang JH, et al. Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): A multicenter study in Korea. J. Korean Med. Sci. 2012; 27: 408-415.
20. Richard N, Komurian-Pradel F, Javouhey E, et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr. Infect. Dis. J. 2008; 27: 213-217.
21. Paranhos-Baccala G, Komurian-Pradel F, Richard N, Vernet G, Lina B, Floret D,. Mixed respiratory virus infections. J. Clin. Virol. 2008; 43: 407-410.
22. Choi EH, Lee HJ, Kim SJ, et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin. Infect. Dis. 2006; 43: 585-592.
23. Fryzek JP, Martone WJ, Groothuis JR,. Trends in chronologic age and infant respiratory syncytial virus hospitalization: An 8-year cohort study. Adv. Ther. 2011; 28: 195-201.
24. Kim CK, Choi J, Callaway Z, et al. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in seoul, Korea, 2003-2008. J. Korean Med. Sci. 2010; 25: 342-347.
25. Simon A, Muller A, Khurana K, et al. Nosocomial infection: A risk factor for a complicated course in children with respiratory syncytial virus infection: Results from a prospective multicenter German surveillance study. Int. J. Hyg. Environ. Health 2008; 211: 241-250.
26. Simon A, Ammann RA, Wilkesmann A, et al. Respiratory syncytial virus infection in 406 hospitalized premature infants: Results from a prospective German multicentre database. Eur. J. Pediatr. 2007; 166: 1273-1283.
27. Carbonell-Estrany X, Bont L, Doering G, Gouyon JB, Lanari M,. Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age. Eur. J. Clin. Microbiol. Infect. Dis. 2008; 27: 891-899.
28. Fodha I, Vabret A, Ghedira L, et al. Respiratory syncytial virus infections in hospitalized infants: Association between viral load, virus subgroup, and disease severity. J. Med. Virol. 2007; 79: 1951-1958.
29. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr. Infect. Dis. J. 2004; 23: 806-814.
30. Horn SD, Smout RJ,. Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J. Pediatr. 2003; 143: S133-141.
31. Fattouh AM, Mansi YA, El-Anany MG, El-Kholy AA, El-Karaksy HM,. Acute lower respiratory tract infection due to respiratory syncytial virus in a group of Egyptian children under 5 years of age. Ital. J. Pediatr. 2011; 37: 14.
32. Groothuis JR, Hoopes JM, Hemming VG,. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis. Adv. Ther. 2011; 28: 110-125.